IGA NEPHROPATHY
Clinical trials for IGA NEPHROPATHY explained in plain language.
Never miss a new study
Get alerted when new IGA NEPHROPATHY trials appear
Sign up with your email to follow new studies for IGA NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug BHV-1400 tested for kidney disease safety
Disease control Recruiting nowThis early-stage study tests whether BHV-1400 is safe for people with IgA nephropathy, a kidney disease. About 20 adults with confirmed IgA nephropathy will receive the drug and be monitored for side effects. The goal is to check safety and tolerability, not yet to measure how we…
Matched conditions: IGA NEPHROPATHY
Phase: PHASE1 • Sponsor: Biohaven Therapeutics Ltd. • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
Last-Resort access opens for kidney disease drug
Disease control AVAILABLEThis program provides early access to the drug EXV811 (atrasentan) for people with IgA nephropathy, a serious kidney disease, who have no other treatment options and cannot join a clinical trial. Doctors can request the drug for their patients if they believe the potential benefi…
Matched conditions: IGA NEPHROPATHY
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC